Personal genome sequencing in ostensibly healthy individuals and the peopleseq consortium

Journal of Personalized Medicine

Volumn 6, Issue 2, 2016, Pages

  Linderman, Michael D ^a   Nielsen, Daiva E ^b,c,d   Green, Robert C ^b,c,d,e  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e LABORATORY FOR MOLECULAR MEDICINE   (United States)

Author keywords

Genomics; Personal genome sequencing; Population screening; Return of results

Indexed keywords

DISEASE SURVEILLANCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOME; HUMAN; MICROBIAL CONSORTIUM; PHARMACOGENOMICS; PSYCHOSOCIAL DEVELOPMENT; REVIEW; RISK ASSESSMENT;

EID: 84988736793     PISSN: None     EISSN: 20754426     Source Type: Journal    
DOI: 10.3390/jpm6020014     Document Type: Review

References (87)

1. Green, R.C.; Berg, J.S.; Grody, W.W.; Kalia, S.S.; Korf, B.R.; Martin, C.L.; McGuire, A.L.; Nussbaum, R.L.; O'Daniel, J.M.; Ormond, K.E.; et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 2013, 15, 565-574. [CrossRef] [PubMed]
2. Church, G.M. The personal genome project. Mol. Syst. Biol. 2005, 1, 2005.0030. [CrossRef] [PubMed]
3. Drmanac, R.; Sparks, A.B.; Callow, M.J.; Halpern, A.L.; Burns, N.L.; Kermani, B.G.; Carnevali, P.; Nazarenko, I.; Nilsen, G.B.; Yeung, G.; et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 2010, 327, 78-81. [CrossRef] [PubMed]
4. Levy, S.; Sutton, G.; Ng, P.C.; Feuk, L.; Halpern, A.L.; Walenz, B.P.; Axelrod, N.; Huang, J.; Kirkness, E.F.; Denisov, G.; et al. The diploid genome sequence of an individual human. PLoS Biol. 2007, 5, e254. [CrossRef] [PubMed]
5. Wheeler, D.A.; Srinivasan, M.; Egholm, M.; Shen, Y.; Chen, L.; McGuire, A.; He, W.; Chen, Y.-J.; Makhijani, V.; Roth, G.T.; et al. The complete genome of an individual by massively parallel DNA sequencing. Nature 2008, 452, 872-876. [CrossRef] [PubMed]
6. Pushkarev, D.; Neff, N.F.; Quake, S.R. Single-molecule sequencing of an individual human genome. Nat. Biotechnol. 2009, 27, 847-850. [CrossRef] [PubMed]
7. Ashley, E.A.; Butte, A.J.; Wheeler, M.T.; Chen, R.; Klein, T.E.; Dewey, F.E.; Dudley, J.T.; Ormond, K.E.; Pavlovic, A.; Morgan, A.A.; et al. Clinical assessment incorporating a personal genome. Lancet 2010, 375, 1525-1535. [CrossRef]
8. Dewey, F.E.; Chen, R.; Cordero, S.P.; Ormond, K.E.; Caleshu, C.; Karczewski, K.J.; Whirl-Carrillo, M.; Wheeler, M.T.; Dudley, J.T.; Byrnes, J.K.; et al. Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet. 2011, 7, e1002280. [CrossRef] [PubMed]
9. Chen, R.; Mias, G.I.; Li-Pook-Than, J.; Jiang, L.; Lam, H.Y.K.; Chen, R.; Miriami, E.; Karczewski, K.J.; Hariharan, M.; Dewey, F.E.; et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012, 148, 1293-1307. [CrossRef] [PubMed]
10. Green, R.C.; Rehm, H.L.; Kohane, I.S. Clinical genome sequencing. In Genomic and Personalized Medicine; Ginsberg, G.S., Willard, H.F., Eds.; Elsevier Science: Philadelphia, PA, USA, 2012; Volumes 1-2, pp. 102-122.
11. Khoury, M.J.; McCabe, L.L.; McCabe, E.R.B. Population screening in the age of genomic medicine. N. Engl. J. Med. 2003, 348, 50-58. [PubMed]
12. ACMG Board of Directors. Points to consider in the clinical application of genomic sequencing. Genet. Med. 2012, 14, 759-761.
13. Adams, M.C.; Evans, J.P.; Henderson, G.E.; Berg, J.S. The promise and peril of genomic screening in the general population. Genet. Med. 2015. [CrossRef] [PubMed]
14. Berg, J.S.; Powell, C.M. Potential uses and inherent challenges of using genome-scale sequencing to augment current newborn screening. Cold Spring Harb. Perspect. Med. 2015, 5, a023150. [CrossRef] [PubMed]
15. Adams, M.C.; Berg, J.S.; Pearlman, M.D.; Vora, N.L. Look before you leap: Genomic screening in obstetrics and gynecology. Obstet. Gynecol. 2015, 125, 1299-1305. [CrossRef] [PubMed]
16. Foulkes,W.D.; Knoppers, B.M.; Turnbull, C. Population genetic testing for cancer susceptibility: Founder mutations to genomes. Nat. Rev. Clin. Oncol. 2016, 13, 41-54. [CrossRef] [PubMed]
17. Vassy, J.L.; Christensen, K.D.; Slashinski, M.J.; Lautenbach, D.M.; Raghavan, S.; Robinson, J.O.; Blumenthal-Barby, J.; Feuerman, L.Z.; Lehmann, L.S.; Murray, M.F.; et al. "Someday it will be the norm": Physician perspectives on the utility of genome sequencing for patient care in the MedSeqProject. Per. Med. 2015, 12, 23-32. [CrossRef] [PubMed]
18. Caskey, C.T.; Gonzalez-Garay, M.L.; Pereira, S.; McGuire, A.L. Adult genetic risk screening. Annu. Rev. Med. 2014, 65, 1-17. [CrossRef] [PubMed]
19. Burke,W.; Korngiebel, D.M. Closing the gap between knowledge and clinical application: Challenges for genomic translation. PLoS Genet. 2015, 11, e1004978. [CrossRef] [PubMed]
20. Scott, S.A. Personalizing medicine with clinical pharmacogenetics. Genet. Med. 2011, 13, 987-995. [CrossRef] [PubMed]
21. Lautenbach, D.M.; Christensen, K.D.; Sparks, J.A.; Green, R.C. Communicating genetic risk information for common disorders in the era of genomic medicine. Annu. Rev. Genomics Hum. Genet. 2013, 14, 491-513. [CrossRef] [PubMed]
22. Green, R.C.; Farahany, N.A. Regulation: The FDA is overcautious on consumer genomics. Nature 2014, 505, 286-287. [CrossRef] [PubMed]
23. Chao, S.; Roberts, J.S.; Marteau, T.M.; Silliman, R.; Cupples, L.A.; Green, R.C. Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study. Alzheimer Dis. Assoc. Disord. 2008, 22, 94-97. doi:10.1097/WAD.0b013e31815a9dcc.
24. Kullo, I.J.; Jouni, H.; Austin, E.E.; Brown, S.-A.; Kruisselbrink, T.M.; Isseh, I.N.; Haddad, R.A.; Marroush, T.S.; Shameer, K.; Olson, J.E.; et al. Incorporating a genetic risk score into coronary heart disease risk estimates: Effect on LDL cholesterol levels (the MIGENES clinical trial). Circulation 2016, CIRCULATIONAHA.115.020109. [CrossRef]
25. Hood, L.; Lovejoy, J.C.; Price, N.D. Integrating big data and actionable health coaching to optimize wellness. BMC Med. 2015, 13, 4. [CrossRef] [PubMed]
26. Terry, S.F.; Terry, P.F. Power to the people: Participant ownership of clinical trial data. Sci. Transl. Med. 2011, 3, 69cm3. [CrossRef] [PubMed]
27. Angrist, M. You never call, you never write: Why return of "omic" results to research participants is both a good idea and a moral imperative. Per. Med. 2011, 8, 651-657. [CrossRef] [PubMed]
28. Wolf, S.M.; Crock, B.N.; Van Ness, B.; Lawrenz, F.; Kahn, J.P.; Beskow, L.M.; Cho, M.K.; Christman, M.F.; Green, R.C.; Hall, R.; et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet. Med. 2012, 14, 361-384. [CrossRef] [PubMed]
29. Wolf, S.M.; Branum, R.; Koenig, B.A.; Petersen, G.M.; Berry, S.A.; Beskow, L.M.; Daly, M.B.; Fernandez, C.V.; Green, R.C.; LeRoy, B.S.; et al. Returning a research participant's genomic results to relatives: Analysis and recommendations. J. Law. Med. Ethics 2015, 43, 440-463. [PubMed]
30. Angrist, M. Eyes wide open: The personal genome project, citizen science and veracity in informed consent. Per. Med. 2009, 6, 691-699. [CrossRef] [PubMed]
31. Flinter, F. Should we sequence everyone's genome? BMJ 2013, 346, 16-17. [CrossRef] [PubMed]
32. Caulfield, T.; Evans, J.; McGuire, A.; McCabe, C.; Bubela, T.; Cook-Deegan, R.; Fishman, J.; Hogarth, S.; Miller, F.A.; Ravitsky, V.; et al. Reflections on the cost of "low-cost" whole genome sequencing: Framing the health policy debate. PLoS Biol. 2013, 11, e1001699. [CrossRef] [PubMed]
33. Diamandis, E.P. The hundred person wellness project and Google's baseline study: Medical revolution or unnecessary and potentially harmful over-testing? BMC Med. 2015, 13, 5. [CrossRef] [PubMed]
34. Arivale. Available online: https://www.arivale.com (accessed on 1 January 2016).
35. Health Nucleus. Available online: https://www.healthnucleus.com (accessed on 11 February 2016).
36. Veritas Genetics. Available online: https://www.veritasgenetics.com (accessed on 7 March 2016).
37. Linderman, M.D.; Bashir, A.; Diaz, G.A.; Kasarskis, A.; Sanderson, S.C.; Zinberg, R.E.; Mahajan, M.; Shah, H.; Suckiel, S.; Zweig, M.; et al. Preparing the next generation of genomicists: A laboratory-style course in medical genomics. BMC Med. Genomics 2015, 8, 47. [CrossRef] [PubMed]
38. The BabySeq Project. Available online: http://www.genomes2people.org/babyseqproject/ (accessed on 3 March 2016).
39. Lunshof, J.E.; Bobe, J.; Aach, J.; Angrist, M.; Thakuria, J.V.; Vorhaus, D.B.; Hoehe, M.R.; Church, G.M. Personal genomes in progress: From the human genome project to the personal genome project. Dialogues Clin. Neurosci. 2010, 12, 47-60. [PubMed]
40. Ball, M.P.; Bobe, J.R.; Chou, M.F.; Clegg, T.; Estep, P.W.; Lunshof, J.E.; Vandewege, W.; Zaranek, A.; Church, G.M. Harvard Personal Genome Project: Lessons from participatory public research. Genome Med. 2014, 6, 10. [CrossRef] [PubMed]
41. Biesecker, L.G.; Mullikin, J.C.; Facio, F.M.; Turner, C.; Cherukuri, P.F.; Blakesley, R.W.; Bouffard, G.G.; Chines, P.S.; Cruz, P.; Hansen, N.F.; et al. The ClinSeq Project: Piloting large-scale genome sequencing for research in genomic medicine. Genome Res. 2009, 19, 1665-1674. [CrossRef] [PubMed]
42. Gonzalez-Garay, M.L.; McGuire, A.L.; Pereira, S.; Caskey, C.T. Personalized genomic disease risk of volunteers. Proc. Natl. Acad. Sci. USA 2013, 110, 16957-16962. [CrossRef] [PubMed]
43. Harrington, E.D.; McLean, C.; Shmygelska, A.; Chowdry, A.; Naughton, B. Considerations for the processing and direct-to-consumer return of exome sequences. In Proceedings of the 62th Annual Meeting of the American Society of Human Genetics, San Francisco, CA, USA, 6-10 November 2012.
44. Shmygelska, A.; Harrington, E.; McLean, C.; Chowdry, A.; Naughton, B. Characterization of sequence variants from the first direct-to-consumer exome pilot project. In Proceedings of the 62th Annual Meeting of The American Society of Human Genetics, San Francisco, CA, USA; 2012.
45. Vassy, J.L.; Lautenbach, D.M.; McLaughlin, H.M.; Kong, S.W.; Christensen, K.D.; Krier, J.; Kohane, I.S.; Feuerman, L.Z.; Blumenthal-Barby, J.; Roberts, J.S.; et al. The MedSeq Project: A randomized trial of integrating whole genome sequencing into clinical medicine. Trials 2014, 15, 85. [CrossRef] [PubMed]
46. Kong, S.W.; Lee, I.-H.; Leshchiner, I.; Krier, J.; Kraft, P.; Rehm, H.L.; Green, R.C.; Kohane, I.S.; MacRae, C.A. Summarizing polygenic risks for complex diseases in a clinical whole-genome report. Genet. Med. 2014, 1, 536-544. [CrossRef] [PubMed]
47. Vassy, J.L.; McLaughlin, H.M.; McLaughlin, H.L.; MacRae, C.A.; Seidman, C.E.; Lautenbach, D.; Krier, J.B.; Lane, W.J.; Kohane, I.S.; Murray, M.F.; et al. A one-page summary report of genome sequencing for the healthy adult. Public Health Genomics 2015, 18, 123-129. [CrossRef] [PubMed]
48. Sanderson, S.C.; Linderman, M.D.; Suckiel, S.A.; Diaz, G.A.; Zinberg, R.E.; Ferryman, K.;Wasserstein, M.; Kasarskis, A.; Schadt, E.E. Motivations, concerns and preferences of personal genome sequencing research participants: Baseline findings from the HealthSeq project. Eur. J. Hum. Genet. 2016, 24, 14-20. [CrossRef] [PubMed]
49. Illumina TruGenome Predisposition Screen. Available online: http://www.illumina.com/content/dam/ illumina-marketing/documents/clinical/trugenome-intended-use-predisposition-screen.pdf (accessed on 8 March 2016).
50. Hunt, K.; McCormick, J.; Lindor, N.; Schahl, K.; Johnson, K.; Mensink, K.; Fiksdal, A.; Highsmith,W.; Klee, E.; Wieben, E. Whole Exome Sequencing of Ten Scientists: Evaluation of Process and Outcomes. In Proceedings of the 2014 ACMG Annual Clinical Genetics Meeting, Nashville, TN, USA, 25-29 March 2014.
51. Dewey, F.E.; Grove, M.E.; Pan, C.; Goldstein, B.A.; Bernstein, J.A.; Chaib, H.; Merker, J.D.; Goldfeder, R.L.; Enns, G.M.; David, S.P.; et al. Clinical interpretation and implications of whole-genome sequencing. JAMA 2014, 311, 1035-1045. [CrossRef] [PubMed]
52. Carey, D.J.; Fetterolf, S.N.; Davis, F.D.; Faucett,W.A.; Kirchner, H.L.; Mirshahi, U.; Murray, M.F.; Smelser, D.T.; Gerhard, G.S.; Ledbetter, D.H. The Geisinger MyCode community health initiative: An electronic health record-linked biobank for precision medicine research. Genet. Med. 2016. [CrossRef] [PubMed]
53. Hood, L.; Price, N.D. Demystifying disease, democratizing health care. Sci. Transl. Med. 2014, 6, 225ed5. [CrossRef] [PubMed]
54. Prince, A.E.R.; Berg, J.S.; Evans, J.P.; Jonas, D.E.; Henderson, G. Genomic screening of the general adult population: Key concepts for assessing net benefit with systematic evidence reviews. Genet. Med. 2015, 17, 441-443. [CrossRef] [PubMed]
55. Baylor Miraca Adult Screening Exome Sequencing. Available online: https://www.bcm.edu/research/ medical-genetics-labs/test_detail.cfm?testcode=1605 (accessed on 3 March 2016).
56. Ormond, K.E. From genetic counseling to "genomic counseling". Mol. Genet. Genomic Med. 2013, 1, 189-193. [CrossRef] [PubMed]
57. Lázaro-Muñoz, G.; Conley, J.M.; Davis, A.M.; Van Riper, M.;Walker, R.L.; Juengst, E.T. Looking for trouble: Preventive Genomic sequencing in the general population and the role of patient choice. Am. J. Bioeth. 2015, 15, 3-14. [CrossRef] [PubMed]
58. Facio, F.M.; Sapp, J.C.; Linn, A.; Biesecker, L.G. Approaches to informed consent for hypothesis-testing and hypothesis-generating clinical genomics research. BMC Med. Genomics 2012, 5, 45. [CrossRef] [PubMed]
59. Facio, F.M.; Brooks, S.; Loewenstein, J.; Green, S.; Biesecker, L.G.; Biesecker, B.B. Motivators for participation in a whole-genome sequencing study: Implications for translational genomics research. Eur. J. Hum. Genet. 2011, 19, 1213-1217. [CrossRef] [PubMed]
60. Facio, F.M.; Eidem, H.; Fisher, T.; Brooks, S.; Linn, A.; Kaphingst, K.A.; Biesecker, L.G.; Biesecker, B.B. Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study. Eur. J. Hum. Genet. 2013, 21, 261-265. [CrossRef] [PubMed]
61. Zierhut, H.; McCarthy Veach, P.; LeRoy, B. Canaries in the coal mine: Personal and professional impact of undergoing whole genome sequencing on medical professionals. Am. J. Med. Genet. A 2015, 167, 2647-2656. [CrossRef] [PubMed]
62. Suckiel, S.A.; Linderman, M.D.; Sanderson, S.C.; Diaz, G.A.; Melissa Kasarskia, A.W.; Schadt, E.E.; Zinberg, R.E. Impact of genomic counseling on informed decision-making among ostensibly healthy individuals seeking personal genome sequencing: The HealthSeq project. J. Genet. Couns. 2016. [CrossRef] [PubMed]
63. Robinson, J.O.; Carroll, T.M.; Feuerman, L.Z.; Perry, D.L.; Hoffman-Andrews, L.; Walsh, R.C.; Christensen, K.D.; Green, R.C.; McGuire, A.L. Participants and study decliners' perspectives about the risks of participating in a clinical trial of whole genome sequencing. J. Empir. Res. Hum. Res. Ethics 2016. [CrossRef] [PubMed]
64. Green, R.C.; Lautenbach, D.; McGuire, A.L. GINA, genetic discrimination, and genomic medicine. N. Engl. J. Med. 2015, 372, 397-399. [CrossRef] [PubMed]
65. McLaughlin, H.M.; Ceyhan-Birsoy, O.; Christensen, K.D.; Kohane, I.S.; Krier, J.; Lane,W.J.; Lautenbach, D.; Lebo, M.S.; Machini, K.; MacRae, C.A.; et al. A systematic approach to the reporting of medically relevant findings from whole genome sequencing. BMC Med. Genet. 2014, 15, 134. [CrossRef] [PubMed]
66. Johnston, J.J.; Lewis, K.L.; Ng, D.; Singh, L.N.; Wynter, J.; Brewer, C.; Brooks, B.P.; Brownell, I.; Candotti, F.; Gonsalves, S.G.; et al. Individualized iterative phenotyping for genome-wide analysis of loss-of-function mutations. Am. J. Hum. Genet. 2015, 96, 913-925. [CrossRef] [PubMed]
67. Johnston, J.J.; Rubinstein, W.S.; Facio, F.M.; Ng, D.; Singh, L.N.; Teer, J.K.; Mullikin, J.C.; Biesecker, L.G. Secondary variants in individuals undergoing exome sequencing: Screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am. J. Hum. Genet. 2012, 91, 97-108. [CrossRef] [PubMed]
68. Dorschner, M.O.; Amendola, L.M.; Turner, E.H.; Robertson, P.D.; Shirts, B.H.; Gallego, C.J.; Bennett, R.L.; Jones, K.L.; Tokita, M.J.; Bennett, J.T.; et al. Actionable, pathogenic incidental findings in 1,000 participants' exomes. Am. J. Hum. Genet. 2013, 93, 631-640. [CrossRef] [PubMed]
69. Gambin, T.; Jhangiani, S.N.; Below, J.E.; Campbell, I.M.; Wiszniewski, W.; Muzny, D.M.; Staples, J.; Morrison, A.C.; Bainbridge, M.N.; Penney, S.; et al. Secondary findings and carrier test frequencies in a large multiethnic sample. Genome Med. 2015, 7, 54. [CrossRef] [PubMed]
70. Ball, M.P.; Thakuria, J.V.; Zaranek, A.W.; Clegg, T.; Rosenbaum, A.M.; Wu, X.; Angrist, M.; Bhak, J.; Bobe, J.; Callow, M.J.; et al. A public resource facilitating clinical use of genomes. Proc. Natl. Acad. Sci. USA 2012, 109, 11920-11927. [CrossRef] [PubMed]
71. Lewis, K.L.; Hooker, G.W.; Connors, P.D.; Hyams, T.C.; Wright, M.F.; Caldwell, S.; Biesecker, L.G.; Biesecker, B.B. Participant use and communication of findings from exome sequencing: A mixed-methods study. Genet. Med. 2015. [CrossRef] [PubMed]
72. Sanderson, S.C.; Linderman, M.D.; Zinberg, R.; Bashir, A.; Kasarskis, A.; Zweig, M.; Suckiel, S.; Shah, H.; Mahajan, M.; Diaz, G.A.; et al. How do students react to analyzing their own genomes in a whole-genome sequencing course? Outcomes of a longitudinal cohort study. Genet. Med. 2015, 17, 866-874. [CrossRef] [PubMed]
73. McGuire, A.L.; Joffe, S.; Koenig, B.A.; Biesecker, B.B.; McCullough, L.B.; Blumenthal-Barby, J.S.; Caulfield, T.; Terry, S.F.; Green, R.C. Point-counterpoint. Ethics and genomic incidental findings. Science 2013, 340, 1047-1048. [CrossRef] [PubMed]
74. Green, R.C.; Lupski, J.R.; Biesecker, L.G. Reporting genomic sequencing results to ordering clinicians: Incidental, but not exceptional. JAMA 2013, 310, 365-366. [CrossRef] [PubMed]
75. Burke, W.; Antommaria, A.H.M.; Bennett, R.; Botkin, J.; Clayton, E.W.; Henderson, G.E.; Holm, I.A.; Jarvik, G.P.; Khoury, M.J.; Knoppers, B.M.; et al. Recommendations for returning genomic incidental findings? We need to talk! Genet. Med. 2013, 15, 854-859. [CrossRef] [PubMed]
76. Vassy, J.L.; Korf, B.R.; Green, R.C. How to know when physicians are ready for genomic medicine. Sci. Transl. Med. 2015, 7, 287fs19. [CrossRef] [PubMed]
77. Christensen, K.D.; Vassy, J.L.; Jamal, L.; Lehmann, L.S.; Slashinski, M.J.; Perry, D.L.; Robinson, J.O.; Blumenthal-Barby, J.; Feuerman, L.Z.; Murray, M.F.; et al. Are physicians prepared for whole genome sequencing? A qualitative analysis. Clin. Genet. 2015. [CrossRef] [PubMed]
78. Feero,W.G.; Manolio, T.A.; Khoury, M.J. Translational research is a key to nongeneticist physicians' genomics education. Genet. Med. 2014, 16, 871-873. [CrossRef] [PubMed]
79. Jarvik, G.P.; Amendola, L.M.; Berg, J.S.; Brothers, K.; Clayton, E.W.; Chung, W.; Evans, B.J.; Evans, J.P.; Fullerton, S.M.; Gallego, C.J.; et al. Return of genomic results to research participants: The floor, the ceiling, and the choices in between. Am. J. Hum. Genet. 2014, 94, 818-826. [CrossRef] [PubMed]
80. Blumenthal-Barby, J.S.; McGuire, A.L.; Green, R.C.; Ubel, P.A. How behavioral economics can help to avoid "The last mile problem" in whole genome sequencing. Genome Med. 2015, 7, 3. [CrossRef] [PubMed]
81. Feero, W.G.; Wicklund, C.; Veenstra, D.L. The economics of genomic medicine: Insights from the IOM Roundtable on Translating Genomic-Based Research for Health. JAMA 2013, 309, 1235-1236. [CrossRef] [PubMed]
82. Helm, M.; Hambuch, T.; Ball, M.; Church, G.; Linderman, M.; Pearson, N.; Roberts, J.S.; Sanderson, S.; Schadt, E.; Green, R.C. Predispositional genome sequencing in healthy adults: Findings from the PeopleSeq Study. In Proceedings the 34th Annual Education Conference of the National Society of Genetic Counselors, Pittsburgh, PA, USA, 21-24 October 2015.
83. Rehm, H.L.; Bale, S.J.; Bayrak-Toydemir, P.; Berg, J.S.; Brown, K.K.; Deignan, J.L.; Friez, M.J.; Funke, B.H.; Hegde, M.R.; Lyon, E. ACMG clinical laboratory standards for next-generation sequencing. Genet. Med. 2013, 15, 733-747. [CrossRef] [PubMed]
84. Richards, S.; Aziz, N.; Bale, S.; Bick, D.; Das, S.; Gastier-Foster, J.; Grody, W.W.; Hegde, M.; Lyon, E.; Spector, E.; et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015, 17, 405-424. [CrossRef] [PubMed]
85. Amendola, L.M.; Jarvik, G.P.; Leo, M.; McLaughlin, H.M.; Akkari, H.; Amaral, M.; Berg, J.S.; Biswas, S.; Bowling, K.; Conlin, L.; et al. Performance of ACMG/AMP variant interpretation guidelines among nine laboratories in the Clinical Sequencing Exploratory Research (CSER) consortium. Am. J. Hum. Genet. 2016. in press.
86. Rehm, H.L.; Berg, J.S.; Brooks, L.D.; Bustamante, C.D.; Evans, J.P.; Landrum, M.J.; Ledbetter, D.H.; Maglott, D.R.; Martin, C.L.; Nussbaum, R.L.; et al. ClinGen-The Clinical Genome Resource. N. Engl. J. Med. 2015, 372, 2235-2242. [CrossRef] [PubMed]
87. Christensen, K.D.; Dukhovny, D.; Siebert, U.; Green, R.C. Assessing the Costs and Cost-Effectiveness of Genomic Sequencing. J. Pers. Med. 2015, 5, 470-486. [CrossRef] [PubMed]